Comparative clinical outcomes and safety of finerenone, SGLT2 inhibitors, RAS inhibitors and ARNI in heart failure with preserved or mildly reduced ejection fraction: a systematic review and network meta-analysis. [PDF]
Front PharmacolFu Z +6 more
europepmc +1 more source
Population Pharmacokinetics of the Novel Myeloperoxidase Inhibitor Mitiperstat. [PDF]
Pharmacol Res PerspectSunnåker M, Leander J, Ericsson H.
europepmc +1 more source
HFrEF, HFmrEF, and HFpEF: Are They a Continuum or Different Faces of a Syndrome?
International Journal of Cardiovascular SciencesEven Edilce Mol +2 more
openaire +2 more sources
Ironing out the details: a comprehensive review of iron therapy in heart failure. [PDF]
Br J CardiolChotalia R, Bakhit Y, Chotalia M, Sze S.
europepmc +1 more source
Health Status in Heart Failure With Preserved Ejection Fraction in Asia: Insights From Global Trials. [PDF]
JACC AsiaHamatani Y +9 more
europepmc +1 more source
The Factors Associated With Readmission in One Year Among Patients With Chronic Heart Failure: A Retrospective Cohort Study. [PDF]
CureusFeng Z +6 more
europepmc +1 more source
Exercise-Induced Alterations in Lung Water Density in Heart Failure Using Single-Breath-Hold 3D Ultrashort Echo Time MRI. [PDF]
J Magn Reson ImagingChen H +8 more
europepmc +1 more source
The influence of C-reactive protein-triglyceride-glucose index (CTI) on the prognosis of heart failure patients with different ejection fractions. [PDF]
Front Cardiovasc MedMa X +8 more
europepmc +1 more source
Beyond Breathlessness Intensity: A Prospective Psychometric Validation of the Multidimensional Dyspnea Profile in Heart Failure with Reduced and Mildly Reduced Ejection Fraction. [PDF]
J Clin MedAldhahi MI, Nazer RI, Albarrati AM.
europepmc +1 more source
Mineralocorticoid receptor antagonists for the treatment of heart failure and kidney disease: a state-of-the-art review. [PDF]
Heart Fail RevVan Spall HGC, Vardeny O.
europepmc +1 more source